These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9798999)

  • 1. Association of red-blood methylfolate but not plasma folate with C677T MTHFR polymorphism in venous thromboembolic disease.
    Quéré I; Wutschert R; Zittoun J; Bellet H; Reber G; Gris JC; Janbon C; Schved JF; de Moerloose P
    Thromb Haemost; 1998 Oct; 80(4):707-9. PubMed ID: 9798999
    [No Abstract]   [Full Text] [Related]  

  • 2. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
    Quéré I; Perneger TV; Zittoun J; Bellet H; Gris JC; Daurès JP; Schved JF; Mercier E; Laroche JP; Dauzat M; Bounameaux H; Janbon C; de Moerloose P
    Lancet; 2002 Mar; 359(9308):747-52. PubMed ID: 11888585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap.
    Smulders YM; Smith DE; Kok RM; Teerlink T; Swinkels DW; Stehouwer CD; Jakobs C
    Br J Haematol; 2006 Mar; 132(5):623-9. PubMed ID: 16445837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
    Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell folate vitamer distribution in healthy subjects is determined by the methylenetetrahydrofolate reductase C677T polymorphism and by the total folate status.
    Smulders YM; Smith DE; Kok RM; Teerlink T; Gellekink H; Vaes WH; Stehouwer CD; Jakobs C
    J Nutr Biochem; 2007 Oct; 18(10):693-9. PubMed ID: 17418558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.
    Friso S; Choi SW; Girelli D; Mason JB; Dolnikowski GG; Bagley PJ; Olivieri O; Jacques PF; Rosenberg IH; Corrocher R; Selhub J
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5606-11. PubMed ID: 11929966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor.
    Molloy AM; Mills JL; Kirke PN; Ramsbottom D; McPartlin JM; Burke H; Conley M; Whitehead AS; Weir DG; Scott JM
    Am J Med Genet; 1998 Jun; 78(2):155-9. PubMed ID: 9674907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte volume, folate levels, and the presence of methylenetetrahydrofolate reductase polymorphism.
    García-García I; García-Fragoso L; Renta J; Arce S; Cadilla CL
    P R Health Sci J; 2002 Mar; 21(1):17-9. PubMed ID: 12013675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.
    Vychytil A; Födinger M; Wölfl G; Enzenberger B; Auinger M; Prischl F; Buxbaum M; Wiesholzer M; Mannhalter C; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1998 Jun; 53(6):1775-82. PubMed ID: 9607212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).
    Lalouschek W; Aull S; Serles W; Wolfsberger M; Deecke L; Pabinger-Fasching I; Mannhalter C
    J Investig Med; 2000 Jan; 48(1):14-20. PubMed ID: 10695265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
    Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study.
    Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR
    Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common genetic variant affecting folate metabolism is not over-represented in chronic fatigue syndrome.
    Harmon DL; McMaster D; McCluskey DR; Shields D; Whitehead AS
    Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():427-9. PubMed ID: 9247678
    [No Abstract]   [Full Text] [Related]  

  • 15. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults.
    Zappacosta B; Graziano M; Persichilli S; Di Castelnuovo A; Mastroiacovo P; Iacoviello L
    Cell Biochem Funct; 2014 Jan; 32(1):1-4. PubMed ID: 24277487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia.
    García-Miss Mdel R; Pérez-Mutul J; López-Canul B; Solís-Rodríguez F; Puga-Machado L; Oxté-Cabrera A; Gurubel-Maldonado J; Arankowsky-Sandoval G
    J Psychiatr Res; 2010 May; 44(7):441-6. PubMed ID: 19939410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
    Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
    Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct association of SLC19A1 polymorphism -43T>C with red cell folate levels and of MTHFR polymorphism 677C>T with plasma folate levels.
    Chatzikyriakidou A; Vakalis KV; Kolaitis N; Kolios G; Naka KK; Michalis LK; Georgiou I
    Clin Biochem; 2008 Feb; 41(3):174-6. PubMed ID: 18053808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.